Precursors / CSBio
CSBio
Cited as California, US
- Syntheses citing them
- 7
- Distinct agents
- 7
- Distinct precursors
- 6
From the manufacturer
No manufacturer-submitted profile yet. Everything above comes from published papers, not from CSBio itself.
From the literature
Precursors named in the literature
Names as written by the authors. Grade, packaging and current availability are not published and have to be confirmed with the supplier.
Where they were used
| Agent | Precursor | Module | Purification | Source |
|---|---|---|---|---|
| [177Lu]Lu-DOTA-LM3 | DOTA-LM3 | Manual synthesis | none | 39046521 2024 Eur J Nucl Med Mol Imaging |
| [161Tb]Tb-DOTA-LM3 | DOTA-LM3 | Manual synthesis | none | 39046521 2024 Eur J Nucl Med Mol Imaging |
| [177Lu]Lu-DOTA-DV1-K-DV3 | DOTA-DV1-K-DV3 | Manual synthesis | none | 39008219 2024 EJNMMI Radiopharm Chem |
| [177Lu]Lu-DOTA-POL3026 | DOTA-POL3026 | Manual synthesis | none | 39008219 2024 EJNMMI Radiopharm Chem |
| [68Ga]Ga-Trivehexin | Trivehexin | iQS-TS | SPE | 39156699 2024 Front Oncol |
| [177Lu]Lu-DOTA-cyclo-MG1 | DOTA-cyclo-MG1 | Kit-based preparation | — | 28728415 2017 Mol Pharm |
| [177Lu]Lu-DOTA-cyclo-MG2 | DOTA-cyclo-MG2 | Kit-based preparation | — | 28728415 2017 Mol Pharm |
Need this precursor?We can point you to suppliers for CSBio, or handle the enquiry for you.
Get in touch